John Wiley & Sons, Inc., The American Society for Pharmacology and Experimental Therapeutics (ASPET) and the British Pharmacological Society (BPS) announced today their partnership to publish the new open access, peer-reviewed journal, Pharmacology Research & Perspectives, which will open for submissions in April 2013.
Pharmacology Research & Perspectives (PR&P) will publish original research, reviews and perspectives in all areas of preclinical and clinical pharmacology, therapeutics, education and related research areas. The journal will serve as the first fully open access journal for ASPET and BPS, and joins their combined portfolio of prestigious peer-reviewed subscription-based scientific journals, such as the Drug Metabolism and Disposition, Journal of Pharmacology and Experimental Therapeutics, Molecular Pharmacology, British Journal of Pharmacology, and British Journal of Clinical Pharmacology.
Editor-in-Chief Dr. Michael J. Curtis obtained his PhD from the University of British Columbia and has been a Reader at King's College London since 1996. Dr. Curtis has extensive editorial experience, serving as Editor-in-Chief of the Journal of Pharmacological and Toxicological Methods and Reviews Editor of British Journal of Pharmacology, among other positions.
"The publication of Pharmacology Research & Perspectives puts the ASPET-BPS-Wiley alliance at the forefront of open access publishing in pharmacology. I am confident that Mike's expertise and insight will ensure we are able to realise the full potential of this exciting opportunity," said Professor Philip Routledge, BPS President.
"ASPET is pleased to be working with the British Pharmacological Society and Wiley to launch this exciting new open access journal. The journal builds on the long-standing excellence of the publications associated with the two scientific societies and we join enthusiastically with Wiley in this new endeavor that will provide additional options for scientists and a forum for new directions in the discipline of pharmacology," commented James E. Barrett, Chair of ASPET's Board of Publications Trustees.
Deborah Dixon, VP, Publishing Director, Wiley, added, "We are extremely pleased to be partnering with two prestigious organizations to publish this new open access journal in pharmacology. It will provide authors worldwide with a high quality publishing option that will be fast and efficient."
All articles in PR&P will be published as fully open access under a Creative Commons License on Wiley Online Library and deposited in PubMed Central immediately upon publication. A publication fee will be payable by authors on acceptance of their articles. Authors affiliated with, or funded by, an organization that has a Wiley Open Access Account can publish without directly paying any publication charges.
The journal expects to publish its first issue in autumn 2013.
Unraveling the complexities of muscle repair in diabetes: A call for targeted research and therapies